Vertex Pharmaceuticals EPS (earnings per share) 1990–2026What is EPS (earnings per share)? EPS (earnings per share) is a company's net income divided by its number of shares: the profit that belongs to each share over a period.
Vertex Pharmaceuticals's diluted EPS in Q3 FY2026, the three months to 30 September 2026, was 2.56 USD, down 39.0% on the same quarter a year before. Vertex Pharmaceuticals's diluted earnings per share over the last twelve months were 15.54 USD, up 9.6% on the twelve months before. In fiscal year 2025 they were 15.32 USD, against a loss of 2.08 USD on the year before.
Last updated 9 Nov 2026 · Next report 11 Feb 2027
EPS
Growth
| Fiscal year | Period ending | EPS | Growth | EPS (basic) |
|---|---|---|---|---|
| TTM | 30 Sept 2026 | 15.54 | +9.59% | 15.66 |
| FY2025 | 31 Dec 2025 | 15.32 | — | 15.46 |
| FY2024 | 31 Dec 2024 | -2.08 | -114.97% | -2.08 |
| FY2023 | 31 Dec 2023 | 13.89 | +8.35% | 14.05 |
| FY2022 | 31 Dec 2022 | 12.82 | +42.29% | 12.97 |
| FY2021 | 31 Dec 2021 | 9.01 | -12.44% | 9.09 |
| FY2020 | 31 Dec 2020 | 10.29 | +128.16% | 10.44 |
| FY2019 | 31 Dec 2019 | 4.51 | -44.25% | 4.58 |
| FY2018 | 31 Dec 2018 | 8.09 | +677.88% | 8.25 |
| FY2017 | 31 Dec 2017 | 1.04 | — | 1.06 |
| FY2016 | 31 Dec 2016 | -0.46 | — | -0.46 |
| FY2015 | 31 Dec 2015 | -2.31 | — | -2.32 |
| FY2014 | 31 Dec 2014 | -3.14 | — | -3.14 |
| FY2013 | 31 Dec 2013 | -1.98 | — | -1.98 |
| FY2012 | 31 Dec 2012 | -0.50 | -457.14% | -0.50 |
| FY2011 | 31 Dec 2011 | 0.14 | — | 0.14 |
| FY2010 | 31 Dec 2010 | -3.77 | — | -3.77 |
| FY2009 | 31 Dec 2009 | -3.70 | — | -3.70 |
| FY2008 | 31 Dec 2008 | -3.27 | — | -3.27 |
| FY2007 | 31 Dec 2007 | -3.03 | — | -3.03 |
| FY2006 | 31 Dec 2006 | -1.83 | — | -1.83 |
| FY2005 | 31 Dec 2005 | -2.28 | — | -2.28 |
| FY2004 | 31 Dec 2004 | -2.12 | — | -2.12 |
| FY2003 | 31 Dec 2003 | -2.56 | — | -2.56 |
| FY2002 | 31 Dec 2002 | -1.43 | — | -1.43 |
| FY2001 | 31 Dec 2001 | -0.89 | — | -0.89 |
| FY2000 | 31 Dec 2000 | -0.59 | — | -0.59 |
| FY1999 | 31 Dec 1999 | -0.80 | — | -0.80 |
| FY1998 | 31 Dec 1998 | -0.65 | — | -0.65 |
| FY1997 | 31 Dec 1997 | -0.41 | — | -0.41 |
| FY1996 | 31 Dec 1996 | -1.07 | — | -1.07 |
| FY1995 | 31 Dec 1995 | -0.63 | — | -0.63 |
| FY1994 | 31 Dec 1994 | -0.56 | -800.00% | -0.56 |
| FY1993 | 31 Dec 1993 | 0.08 | — | 0.08 |
| FY1992 | 31 Dec 1992 | -0.35 | — | -0.35 |
| FY1991 | 31 Dec 1991 | -0.35 | — | -0.35 |
| FY1990 | 31 Dec 1990 | -0.22 | — | -0.22 |
| Quarter | Period ending | EPS | Growth on a year before | EPS (basic) |
|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 2.56 | -39.05% | 2.58 |
| Q2 FY2026 | 30 Jun 2026 | 4.31 | +8.02% | 4.33 |
| Q1 FY2026 | 31 Mar 2026 | 4.02 | +61.45% | 4.06 |
| Q4 FY2025 | 31 Dec 2025 | 4.65 | +32.86% | 4.69 |
| Q3 FY2025 | 30 Sept 2025 | 4.20 | +4.74% | 4.24 |
| Q2 FY2025 | 30 Jun 2025 | 3.99 | — | 4.02 |
| Q1 FY2025 | 31 Mar 2025 | 2.49 | -40.86% | 2.52 |
| Q4 FY2024 | 31 Dec 2024 | 3.50 | -5.66% | 3.55 |
| Q3 FY2024 | 30 Sept 2024 | 4.01 | +1.01% | 4.05 |
| Q2 FY2024 | 30 Jun 2024 | -13.92 | -495.45% | -13.92 |
| Q1 FY2024 | 31 Mar 2024 | 4.21 | +56.51% | 4.26 |
| Q4 FY2023 | 31 Dec 2023 | 3.71 | +17.78% | 3.76 |
| Q3 FY2023 | 30 Sept 2023 | 3.97 | +10.58% | 4.01 |
| Q2 FY2023 | 30 Jun 2023 | 3.52 | +12.46% | 3.55 |
| Q1 FY2023 | 31 Mar 2023 | 2.69 | -9.12% | 2.72 |
| Q4 FY2022 | 31 Dec 2022 | 3.15 | +5.00% | 3.19 |
| Q3 FY2022 | 30 Sept 2022 | 3.59 | +9.45% | 3.63 |
| Q2 FY2022 | 30 Jun 2022 | 3.13 | +1,103.85% | 3.17 |
| Q1 FY2022 | 31 Mar 2022 | 2.96 | +18.88% | 2.99 |
| Q4 FY2021 | 31 Dec 2021 | 3.00 | +30.43% | 3.02 |
| Q3 FY2021 | 30 Sept 2021 | 3.28 | +29.64% | 3.30 |
| Q2 FY2021 | 30 Jun 2021 | 0.26 | -91.82% | 0.26 |
| Q1 FY2021 | 31 Mar 2021 | 2.49 | +8.73% | 2.52 |
| Q4 FY2020 | 31 Dec 2020 | 2.30 | +3.14% | 2.32 |
| Q3 FY2020 | 30 Sept 2020 | 2.53 | +1,050.00% | 2.56 |
| Q2 FY2020 | 30 Jun 2020 | 3.18 | +208.74% | 3.22 |
| Q1 FY2020 | 31 Mar 2020 | 2.29 | +122.33% | 2.32 |
| Q4 FY2019 | 31 Dec 2019 | 2.23 | -62.65% | 2.26 |
| Q3 FY2019 | 30 Sept 2019 | 0.22 | -56.00% | 0.22 |
| Q2 FY2019 | 30 Jun 2019 | 1.03 | +28.75% | 1.04 |
| Q1 FY2019 | 31 Mar 2019 | 1.03 | +27.16% | 1.05 |
| Q4 FY2018 | 31 Dec 2018 | 5.97 | +1,430.77% | 6.08 |
| Q3 FY2018 | 30 Sept 2018 | 0.50 | — | 0.51 |
| Q2 FY2018 | 30 Jun 2018 | 0.80 | +1,042.86% | 0.82 |
| Q1 FY2018 | 31 Mar 2018 | 0.81 | -18.18% | 0.83 |
| Q4 FY2017 | 31 Dec 2017 | 0.39 | +200.00% | 0.40 |
| Q3 FY2017 | 30 Sept 2017 | -0.41 | — | -0.41 |
| Q2 FY2017 | 30 Jun 2017 | 0.07 | — | 0.07 |
| Q1 FY2017 | 31 Mar 2017 | 0.99 | — | 1.01 |
| Q4 FY2016 | 31 Dec 2016 | 0.13 | — | 0.13 |
| Q3 FY2016 | 30 Sept 2016 | -0.17 | — | -0.17 |
| Q2 FY2016 | 30 Jun 2016 | -0.26 | — | -0.26 |
| Q1 FY2016 | 31 Mar 2016 | -0.17 | — | -0.17 |
| Q4 FY2015 | 31 Dec 2015 | -0.31 | — | -0.31 |
| Q3 FY2015 | 30 Sept 2015 | -0.39 | — | -0.39 |
| Q2 FY2015 | 30 Jun 2015 | -0.78 | — | -0.78 |
| Q1 FY2015 | 31 Mar 2015 | -0.83 | — | -0.83 |
| Q4 FY2014 | 31 Dec 2014 | -0.74 | -489.47% | -0.74 |
| Q3 FY2014 | 30 Sept 2014 | -0.72 | — | -0.72 |
| Q2 FY2014 | 30 Jun 2014 | -0.68 | — | -0.68 |
| Q1 FY2014 | 31 Mar 2014 | -1.00 | — | -1.00 |
| Q4 FY2013 | 31 Dec 2013 | 0.19 | — | 0.19 |
| Q3 FY2013 | 30 Sept 2013 | -0.54 | — | -0.54 |
| Q2 FY2013 | 30 Jun 2013 | -0.26 | — | -0.26 |
| Q1 FY2013 | 31 Mar 2013 | -1.43 | -432.56% | -1.43 |
| Q4 FY2012 | 31 Dec 2012 | -0.35 | -148.61% | -0.35 |
| Q3 FY2012 | 30 Sept 2012 | -0.27 | -126.47% | -0.27 |
| Q2 FY2012 | 30 Jun 2012 | -0.31 | — | -0.31 |
| Q1 FY2012 | 31 Mar 2012 | 0.43 | — | 0.44 |
| Q4 FY2011 | 31 Dec 2011 | 0.72 | — | 0.76 |
| Q3 FY2011 | 30 Sept 2011 | 1.02 | — | 1.06 |
| Q2 FY2011 | 30 Jun 2011 | -0.85 | — | -0.85 |
| Q1 FY2011 | 31 Mar 2011 | -0.87 | — | -0.87 |
| Q4 FY2010 | 31 Dec 2010 | -0.89 | — | -0.89 |
| Q3 FY2010 | 30 Sept 2010 | -1.04 | — | -1.04 |
| Q2 FY2010 | 30 Jun 2010 | -1.00 | — | -1.00 |
| Q1 FY2010 | 31 Mar 2010 | -0.83 | — | -0.83 |
| Q4 FY2009 | 31 Dec 2009 | -0.80 | — | -0.80 |
| Q3 FY2009 | 30 Sept 2009 | -0.84 | — | -0.84 |
| Q2 FY2009 | 30 Jun 2009 | -0.99 | — | -0.99 |
| Q1 FY2009 | 31 Mar 2009 | -1.04 | — | -1.04 |
| Q4 FY2008 | 31 Dec 2008 | -0.91 | — | -0.91 |
| Q3 FY2008 | 30 Sept 2008 | -0.93 | — | -0.93 |
| Q2 FY2008 | 30 Jun 2008 | -0.66 | — | -0.66 |
| Q1 FY2008 | 31 Mar 2008 | -0.72 | — | -0.72 |
| Q4 FY2007 | 31 Dec 2007 | -0.64 | — | -0.64 |
| Q3 FY2007 | 30 Sept 2007 | -0.82 | — | -0.82 |
| Q2 FY2007 | 30 Jun 2007 | -0.91 | — | -0.91 |
| Q1 FY2007 | 31 Mar 2007 | -0.64 | — | -0.64 |
| Q4 FY2006 | 31 Dec 2006 | -0.22 | — | -0.22 |
| Q3 FY2006 | 30 Sept 2006 | -0.46 | — | -0.46 |
| Q2 FY2006 | 30 Jun 2006 | -0.72 | — | -0.72 |
| Q1 FY2006 | 31 Mar 2006 | -0.47 | — | -0.47 |
| Q4 FY2005 | 31 Dec 2005 | -0.35 | — | -0.35 |
| Q3 FY2005 | 30 Sept 2005 | -0.84 | — | -0.84 |
| Q2 FY2005 | 30 Jun 2005 | -0.50 | — | -0.50 |
| Q1 FY2005 | 31 Mar 2005 | -0.56 | — | -0.56 |
| Q4 FY2004 | 31 Dec 2004 | -0.54 | — | -0.54 |
| Q3 FY2004 | 30 Sept 2004 | -0.49 | — | -0.49 |
| Q2 FY2004 | 30 Jun 2004 | -0.56 | — | -0.56 |
| Q1 FY2004 | 31 Mar 2004 | -0.52 | -292.59% | -0.52 |
| Q4 FY2003 | 31 Dec 2003 | -0.53 | — | -0.53 |
| Q3 FY2003 | 30 Sept 2003 | -1.12 | — | -1.12 |
| Q2 FY2003 | 30 Jun 2003 | -0.60 | — | -0.60 |
| Q1 FY2003 | 31 Mar 2003 | 0.27 | — | 0.27 |
| Q4 FY2002 | 31 Dec 2002 | -0.42 | — | -0.42 |
| Q3 FY2002 | 30 Sept 2002 | -0.44 | — | -0.44 |
| Q2 FY2002 | 30 Jun 2002 | -0.28 | — | -0.28 |
| Q1 FY2002 | 31 Mar 2002 | -0.29 | — | -0.29 |
| Q4 FY2001 | 31 Dec 2001 | -0.04 | — | -0.04 |
| Q3 FY2001 | 30 Sept 2001 | -0.63 | — | -0.63 |
| Q2 FY2001 | 30 Jun 2001 | -0.20 | -195.24% | -0.20 |
| Q1 FY2001 | 31 Mar 2001 | -0.15 | — | -0.15 |
| Q4 FY2000 | 31 Dec 2000 | -0.19 | -675.76% | -0.19 |
| Q3 FY2000 | 30 Sept 2000 | -0.46 | — | -0.46 |
| Q2 FY2000 | 30 Jun 2000 | 0.21 | — | 0.24 |
| Q1 FY2000 | 31 Mar 2000 | -0.31 | — | -0.31 |
| Q4 FY1999 | 31 Dec 1999 | 0.03 | — | 0.03 |
| Q3 FY1999 | 30 Sept 1999 | -0.28 | — | -0.28 |
| Q2 FY1999 | 30 Jun 1999 | -0.21 | — | -0.21 |
| Q1 FY1999 | 31 Mar 1999 | -0.35 | — | -0.35 |
| Q4 FY1998 | 31 Dec 1998 | -0.25 | — | -0.25 |
| Q3 FY1998 | 30 Sept 1998 | -0.05 | — | -0.05 |
| Q2 FY1998 | 30 Jun 1998 | -0.20 | — | -0.20 |
| Q1 FY1998 | 31 Mar 1998 | -0.17 | — | -0.17 |
| Q4 FY1997 | 31 Dec 1997 | -0.14 | — | -0.14 |
| Q3 FY1997 | 30 Sept 1997 | -0.12 | — | -0.12 |
| Q2 FY1997 | 30 Jun 1997 | -0.03 | — | -0.03 |
| Q1 FY1997 | 31 Mar 1997 | -0.13 | — | -0.13 |
| Q4 FY1996 | 31 Dec 1996 | -0.09 | — | -0.09 |
| Q3 FY1996 | 30 Sept 1996 | -0.17 | — | -0.17 |
| Q2 FY1996 | 30 Jun 1996 | -0.64 | — | -0.64 |
| Q1 FY1996 | 31 Mar 1996 | -0.22 | — | -0.22 |
| Q4 FY1995 | 31 Dec 1995 | -0.02 | — | -0.02 |
| Q3 FY1995 | 30 Sept 1995 | -0.20 | — | -0.20 |
| Q2 FY1995 | 30 Jun 1995 | -0.26 | — | -0.26 |
| Q1 FY1995 | 31 Mar 1995 | -0.14 | — | -0.14 |
| Q4 FY1994 | 31 Dec 1994 | -0.15 | -150.00% | -0.15 |
| Q3 FY1994 | 30 Sept 1994 | -0.12 | — | -0.12 |
| Q2 FY1994 | 30 Jun 1994 | -0.18 | — | -0.18 |
| Q1 FY1994 | 31 Mar 1994 | -0.11 | — | -0.11 |
| Q4 FY1993 | 31 Dec 1993 | 0.30 | — | 0.30 |
| Q3 FY1993 | 30 Sept 1993 | -0.11 | — | -0.11 |
| Q2 FY1993 | 30 Jun 1993 | -0.03 | — | -0.03 |
| Q1 FY1993 | 31 Mar 1993 | -0.14 | — | -0.14 |
| Q4 FY1992 | 31 Dec 1992 | -0.11 | — | -0.11 |
| Q3 FY1992 | 30 Sept 1992 | -0.09 | — | -0.09 |
| Q2 FY1992 | 30 Jun 1992 | -0.08 | — | -0.08 |
| Q1 FY1992 | 31 Mar 1992 | -0.07 | — | -0.07 |
| Q4 FY1991 | 31 Dec 1991 | -0.06 | — | -0.06 |
| Q3 FY1991 | 30 Sept 1991 | -0.07 | — | -0.07 |
| Q2 FY1991 | 30 Jun 1991 | -0.07 | — | -0.07 |
| Q1 FY1991 | 31 Mar 1991 | -0.06 | — | -0.06 |
| Q4 FY1990 | 31 Dec 1990 | -0.06 | — | -0.06 |
| Q3 FY1990 | 30 Sept 1990 | -0.06 | — | -0.06 |
| Q2 FY1990 | 30 Jun 1990 | -0.06 | — | -0.06 |
| Q1 FY1990 | 31 Mar 1990 | -0.05 | — | -0.05 |
Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.
See also:Revenue,Net income,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement
Common questions about Vertex Pharmaceuticals's EPS
Source: Financial Modeling Prep
